PNC Financial Services Group
ARKG icon

PNC Financial Services Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

PNC Financial Services Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.3K Sell
910
-178
-16% -$5.67K ﹤0.01% 3489
2026
Q1 		$28.7K Buy
1,088
+378
+53% +$11.1K ﹤0.01% 3522
2025
Q4 		$20.6K Buy
710
+570
+407% +$17.1K ﹤0.01% 3641
2025
Q3 		$3.89K Sell
140
-1,604
-92% -$40.5K ﹤0.01% 4301
2025
Q2 		$42.5K Hold
1,744
– – ﹤0.01% 3197
2025
Q1 		$36.2K Hold
1,744
– – ﹤0.01% 3265
2024
Q4 		$41.1K Sell
1,744
-195
-10% -$4.8K ﹤0.01% 3207
2024
Q3 		$49.6K Sell
1,939
-149
-7% -$3.79K ﹤0.01% 3095
2024
Q2 		$49K Sell
2,088
-1,849
-47% -$46.7K ﹤0.01% 3046
2024
Q1 		$113K Sell
3,937
-296
-7% -$8.9K ﹤0.01% 2541
2023
Q4 		$139K Sell
4,233
-217
-5% -$5.9K ﹤0.01% 2397
2023
Q3 		$124K Sell
4,450
-789
-15% -$25.8K ﹤0.01% 2436
2023
Q2 		$179K Buy
5,239
+947
+22% +$29.8K ﹤0.01% 2284
2023
Q1 		$129K Hold
4,292
– – ﹤0.01% 2410
2022
Q4 		$121K Buy
4,292
+818
+24% +$26K ﹤0.01% 2447
2022
Q3 		$115K Sell
3,474
-587
-14% -$21.6K ﹤0.01% 2443
2022
Q2 		$128K Sell
4,061
-1,084
-21% -$37.9K ﹤0.01% 2404
2022
Q1 		$236K Buy
5,145
+350
+7% +$16.7K ﹤0.01% 2146
2021
Q4 		$294K Sell
4,795
-7,437
-61% -$514K ﹤0.01% 2021
2021
Q3 		$915K Sell
12,232
-350
-3% -$29.4K ﹤0.01% 1240
2021
Q2 		$1.16M Sell
12,582
-1,073
-8% -$91.2K ﹤0.01% 1133
2021
Q1 		$1.21M Buy
13,655
+5,905
+76% +$586K ﹤0.01% 1081
2020
Q4 		$723K Buy
7,750
+1,558
+25% +$124K ﹤0.01% 1279
2020
Q3 		$394K Buy
6,192
+3,344
+117% +$196K ﹤0.01% 1490
2020
Q2 		$148K Sell
2,848
-52
-2% -$2.23K ﹤0.01% 2093
2020
Q1 		$90K Hold
2,900
– – ﹤0.01% 2260
2019
Q4 		$98K Buy
+2,900
New +$92.1K ﹤0.01% 2503
2019
Q1 		– Sell
-1,013
Closed -$24K – 4017
2018
Q4 		$24K Hold
1,013
– – ﹤0.01% 3224
2018
Q3 		$34K Buy
+1,013
New +$32.1K ﹤0.01% 3223

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PNC Financial Services Group's ARKG Position: Q2 2026 in Review

PNC Financial Services Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 16% in Q2 2026, selling an estimated $5.67K and leaving 910 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3489.

PNC Financial Services Group first reported a position in ARKG in Q3 2018 and has held it in 29 quarters since. The position peaked at $1.21M in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • PNC Financial Services Group held 910 shares of ARK Genomic Revolution ETF worth $38.3K as of Q2 2026.
  • PNC Financial Services Group sold 178 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $5.67K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3489 holding.
  • PNC Financial Services Group first reported a position in ARK Genomic Revolution ETF in Q3 2018 and has held it in 29 quarters since.
  • PNC Financial Services Group's ARK Genomic Revolution ETF position peaked at $1.21M in Q1 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.